Ignace Vergote
MD
Professor of Gynecologic Oncology
👥Biography 个人简介
Ignace Vergote at Leuven led the EORTC 55971 trial demonstrating that neoadjuvant chemotherapy followed by interval debulking surgery was non-inferior to primary debulking surgery in advanced ovarian cancer — a landmark result that changed surgical management for a substantial proportion of patients. His extensive contributions to ovarian cancer surgical research and European gynecologic oncology cooperative group trials have shaped practice standards.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ignace Vergote 的研究动态
Follow Ignace Vergote's research updates
留下邮箱，当我们发布与 Ignace Vergote（University Hospitals Leuven）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment